Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06579976

Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity Index

Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity Index:a Prospective Cohort Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
Shanghai Yueyang Integrated Medicine Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Psoriasis (PsO) is a common chronic relapsing inflammatory disease, induced by a combination of genetic and environmental effects, which seriously affects the quality of life of patients.Psoriasis Area and Severity Index(PASI score ) ,as the most common method used by clinicians to assess the severity of psoriasis and the effectiveness of treatment, has the disadvantage of being subjective and superficial.We are therefore committed to establishing an objective, real-time, repeatable, non-invasive, microscopic assessment using high-frequency ultrasound. This study will use high-frequency ultrasound to detect the patient's lesion site and the 2cm site next to the lesion once, and the study will continue to recruit for 6 months.

Detailed description

High-frequency ultrasound (HFUS) with a center frequency of more than 10 MHz, and a resolution of 16-158 μm. The detailed detection items are epidermal thickness (unit mm), dermal thickness (unit mm), hypoechoic cord thickness between epidermis and dermis (unit mm), epidermal echo intensity, dermal echo intensity, clarity of the boundary between dermis and subcutaneous tissue detected by Grayscale ultrasound; blood flow signal (pcs) detected by Color Doppler imaging and Power doppler imaging. The 8 tests will be detected the skin lesions and 2cm beside skin lesions area.Based on the correlation between the 8 indexes and local PASI scores, we will establish a model for the evaluation of psoriasis by multimodal high-frequency ultrasound.This study will use high-frequency ultrasound to detect the patient's lesion site and the 2cm site next to the lesion once, and the study will continue to recruit for 6 months

Conditions

Interventions

TypeNameDescription
OTHERNo interventionThis is an observational study, no intervention will be implemented.

Timeline

Start date
2024-09-01
Primary completion
2025-02-28
Completion
2025-05-01
First posted
2024-08-30
Last updated
2024-08-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06579976. Inclusion in this directory is not an endorsement.